These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 11868286

  • 1. Impact of orlistat therapy on weight reduction in morbidly obese patients after implantation of the Swedish adjustable gastric band.
    Zoss I, Piec G, Horber FF.
    Obes Surg; 2002 Feb; 12(1):113-7. PubMed ID: 11868286
    [Abstract] [Full Text] [Related]

  • 2. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H, Ziegler O, Keller U, Hamann A, Godin C, Wittert G, Zanella MT, Zúñiga-Guajardo S, Van Gaal L.
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [Abstract] [Full Text] [Related]

  • 3. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G, Cicero AF, Murdolo G, Ciccarelli L, Fogari R.
    Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
    [Abstract] [Full Text] [Related]

  • 4. The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome.
    Svendsen M, Helgeland M, Tonstad S.
    J Hum Nutr Diet; 2009 Feb; 22(1):55-63. PubMed ID: 19192027
    [Abstract] [Full Text] [Related]

  • 5. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
    Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA.
    Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
    [Abstract] [Full Text] [Related]

  • 6. Resting energy expenditure and fuel metabolism following laparoscopic adjustable gastric banding in severely obese women: relationships with excess weight lost.
    Galtier F, Farret A, Verdier R, Barbotte E, Nocca D, Fabre JM, Bringer J, Renard E.
    Int J Obes (Lond); 2006 Jul; 30(7):1104-10. PubMed ID: 16477271
    [Abstract] [Full Text] [Related]

  • 7. An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: comorbidity resolution and compliance data.
    Nadler EP, Youn HA, Ren CJ, Fielding GA.
    J Pediatr Surg; 2008 Jan; 43(1):141-6. PubMed ID: 18206472
    [Abstract] [Full Text] [Related]

  • 8. Comparison of weight loss and body composition changes with four surgical procedures.
    Strain GW, Gagner M, Pomp A, Dakin G, Inabnet WB, Hsieh J, Heacock L, Christos P.
    Surg Obes Relat Dis; 2009 Jan; 5(5):582-7. PubMed ID: 19560983
    [Abstract] [Full Text] [Related]

  • 9. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.
    Richelsen B, Tonstad S, Rössner S, Toubro S, Niskanen L, Madsbad S, Mustajoki P, Rissanen A.
    Diabetes Care; 2007 Jan; 30(1):27-32. PubMed ID: 17192328
    [Abstract] [Full Text] [Related]

  • 10. Prevalent esophageal body motility disorders underlie aggravation of GERD symptoms in morbidly obese patients following adjustable gastric banding.
    Klaus A, Gruber I, Wetscher G, Nehoda H, Aigner F, Peer R, Margreiter R, Weiss H.
    Arch Surg; 2006 Mar; 141(3):247-51. PubMed ID: 16549689
    [Abstract] [Full Text] [Related]

  • 11. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
    Tzotzas T, Samara M, Constantinidis T, Tziomalos K, Krassas G.
    Angiology; 2007 Mar; 58(1):26-33. PubMed ID: 17351155
    [Abstract] [Full Text] [Related]

  • 12. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.
    Kiortsis DN, Tsouli S, Filippatos TD, Konitsiotis S, Elisaf MS.
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):207-10. PubMed ID: 17570651
    [Abstract] [Full Text] [Related]

  • 13. Vertical banded gastroplasty versus adjustable gastric banding: prospective long-term follow-up study.
    Miller K, Pump A, Hell E.
    Surg Obes Relat Dis; 2007 Mar; 3(1):84-90. PubMed ID: 17116427
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
    Stephens DJ, Saunders JK, Belsley S, Trivedi A, Ewing DR, Iannace V, Capella RF, Wasielewski A, Moran S, Schmidt HJ, Ballantyne GH.
    Surg Obes Relat Dis; 2008 Mar; 4(3):408-15. PubMed ID: 18243060
    [Abstract] [Full Text] [Related]

  • 17. Laparoscopic adjustable gastric banding: a prospective comparison of two commonly used bands.
    Ponson AE, Janssen IM, Klinkenbijl JH.
    Obes Surg; 2002 Aug; 12(4):579-82. PubMed ID: 12194555
    [Abstract] [Full Text] [Related]

  • 18. Daily high doses of fluoxetine for weight loss and improvement in lifestyle before bariatric surgery.
    Dolfing JG, Wolffenbuttel BH, ten Hoor-Aukema NM, Schweitzer DH.
    Obes Surg; 2005 Sep; 15(8):1185-91. PubMed ID: 16197794
    [Abstract] [Full Text] [Related]

  • 19. Laparoscopic gastric banding and body composition in morbid obesity.
    Guida B, Belfiore A, Angrisani L, Micanti F, Mauriello C, Trio R, Pecoraro P, Falconi C.
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):198-203. PubMed ID: 15955468
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of sibutramine and orlistat on obese, poorly-controlled type 2 diabetic patients.
    Chou KM, Huang BY, Fanchiang JK, Chen CH.
    Chang Gung Med J; 2007 Jun; 30(6):538-46. PubMed ID: 18350737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.